Lexeo Therapeutics (LXEO) Stock Chart & Stock Price History → Elon Musk’s Final Masterpiece: “X-9840” (From Paradigm Press) (Ad) Free LXEO Stock Alerts $17.25 -0.20 (-1.15%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Lexeo Therapeutics Stock Price Performance5 Day Performance+1.17%1 Month Performance+25.73%3 Month Performance+14.01%6 Month Performance+48.84%Year-To-Date Performance+28.54% Receive LXEO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lexeo Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressAfter Conviction, More Bad News for TrumpAs a former advisor to the CIA, the Pentagon and the White House… I feel it’s my duty to warn you about this coming election meltdown.Click here to see the details because this coming election meltdown could trigger… LXEO Stock Chart for Saturday, June, 8, 2024 LXEO Chart by TradingView Lexeo Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$17.45$17.25-1.15%$17.65$16.85121,030 shs$568.22 million06/06/2024$17.19$17.45+1.51%$17.99$17.24346,962 shs$574.80 million06/05/2024$17.10$17.19+0.53%$17.59$16.55244,342 shs$566.24 million06/04/2024$17.05$17.10+0.29%$17.40$16.40183,464 shs$563.27 million06/03/2024$16.63$17.05+2.53%$17.32$15.32219,238 shs$561.71 million05/31/2024$16.05$16.63+3.61%$16.80$15.85233,499 shs$547.79 million Get the Latest News and Ratings for LXEO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexeo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$15.19$16.05+5.66%$16.43$15.26170,024 shs$528.69 million05/29/2024$15.00$15.19+1.27%$15.55$14.7462,664 shs$500.44 million05/28/2024$15.46$15.00-2.98%$15.57$14.53149,842 shs$494.10 million05/27/2024$15.46$15.46$15.61$15.0877,200 shs$509.25 million05/24/2024$15.48$15.46-0.13%$15.61$15.0877,249 shs$509.33 million05/23/2024$15.16$15.48+2.11%$16.20$15.1587,598 shs$509.91 million05/22/2024$15.00$15.16+1.07%$15.48$14.83109,674 shs$499.37 million05/21/2024$13.77$15.00+8.93%$15.56$13.77307,611 shs$494.10 million05/20/2024$13.85$13.77-0.58%$14.26$13.4878,474 shs$453.58 million05/17/2024$14.02$13.85-1.21%$14.28$13.7250,716 shs$456.22 million05/16/2024$13.96$14.02+0.43%$15.15$13.82335,730 shs$461.82 million05/15/2024$13.97$13.96-0.07%$15.00$13.7577,472 shs$459.84 million05/14/2024$13.56$13.97+3.02%$14.53$13.5977,448 shs$460.17 million05/13/2024$13.14$13.56+3.20%$13.56$12.9862,196 shs$446.67 million05/10/2024$14.50$13.14-9.38%$14.48$13.0292,011 shs$432.90 million05/09/2024$13.72$14.50+5.69%$16.79$13.44245,663 shs$477.63 million05/08/2024$13.43$13.72+2.16%$14.01$13.0856,954 shs$451.94 million05/07/2024$13.21$13.43+1.67%$13.55$12.98100,116 shs$442.38 million05/06/2024$12.77$13.21+3.45%$13.46$12.78253,428 shs$435.14 million05/03/2024$12.46$12.77+2.49%$13.11$12.6198,948 shs$420.64 million05/02/2024$12.30$12.46+1.30%$12.52$12.13162,808 shs$410.43 million05/01/2024$12.45$12.30-1.20%$12.66$12.2079,028 shs$405.16 million04/30/2024$12.30$12.45+1.22%$13.33$12.40113,579 shs$410.23 million04/29/2024$12.50$12.30-1.60%$12.97$12.00209,037 shs$405.29 million04/26/2024$12.16$12.50+2.80%$12.86$11.99377,218 shs$411.88 million04/25/2024$12.50$12.16-2.72%$12.47$11.9051,316 shs$400.65 million04/24/2024$12.14$12.50+2.97%$12.53$11.7699,355 shs$411.88 million04/23/2024$12.66$12.14-4.11%$12.79$12.1282,174 shs$400.01 million04/22/2024$12.05$12.66+5.06%$13.10$12.05229,958 shs$417.15 million04/19/2024$12.07$12.05-0.17%$12.39$11.7186,684 shs$397.05 million04/18/2024$12.26$12.07-1.55%$12.26$11.5783,451 shs$397.71 million04/17/2024$12.23$12.26+0.25%$12.49$11.8992,426 shs$403.97 million04/16/2024$12.09$12.23+1.16%$12.56$11.6578,026 shs$402.98 million04/15/2024$12.23$12.09-1.14%$12.25$11.73105,400 shs$398.37 millionBreaking - The US Gov. Seized CITGO (Ad)Do you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).Get all the details here.04/12/2024$13.06$12.23-6.36%$12.83$12.0044,755 shs$402.98 million04/11/2024$12.49$13.06+4.56%$13.13$12.2637,009 shs$348.30 million04/10/2024$13.45$12.49-7.14%$13.45$12.0096,808 shs$333.11 million04/09/2024$13.16$13.45+2.20%$15.06$12.93108,739 shs$358.71 million04/08/2024$12.99$13.16+1.31%$13.36$11.88106,819 shs$350.98 million04/05/2024$13.12$12.99-0.99%$13.38$12.7962,780 shs$346.44 million04/04/2024$14.15$13.12-7.28%$14.68$13.1157,766 shs$349.91 million04/03/2024$14.60$14.15-3.08%$14.70$14.0351,973 shs$377.38 million04/02/2024$15.85$14.60-7.89%$15.78$14.31133,162 shs$389.38 million04/01/2024$15.68$15.85+1.08%$16.02$15.0177,746 shs$422.70 million03/29/2024$15.68$15.68$15.84$15.1378,012 shs$418.19 million03/28/2024$15.27$15.68+2.69%$15.84$15.1378,012 shs$418.19 million03/27/2024$14.72$15.27+3.74%$15.41$14.6062,699 shs$407.25 million03/26/2024$14.62$14.72+0.68%$14.83$14.3948,255 shs$392.57 million03/25/2024$14.50$14.62+0.83%$15.03$14.2058,334 shs$389.92 million03/22/2024$15.02$14.50-3.46%$15.36$14.3968,698 shs$386.72 million03/21/2024$15.15$15.02-0.86%$15.57$14.6583,739 shs$400.58 million03/20/2024$15.01$15.15+0.93%$15.49$14.5080,168 shs$404.05 million03/19/2024$15.71$15.01-4.46%$16.20$14.53119,442 shs$400.32 million03/18/2024$15.57$15.71+0.90%$15.97$14.51173,732 shs$418.99 million03/15/2024$15.68$15.57-0.70%$16.84$15.201.26 million shs$415.25 million03/14/2024$16.58$15.68-5.43%$16.94$15.03110,576 shs$417.87 million03/13/2024$15.69$16.58+5.67%$17.11$15.59147,606 shs$441.86 million03/12/2024$14.49$15.69+8.28%$16.03$14.74192,605 shs$418.08 million03/11/2024$15.13$14.49-4.23%$16.17$13.55289,466 shs$386.16 million03/08/2024$14.68$15.13+3.07%$15.41$14.6366,304 shs$403.21 million03/07/2024$14.75$14.68-0.47%$15.60$14.3756,123 shs$391.16 million Related Companies: Recursion Pharmaceuticals Stock Chart Beam Therapeutics Stock Chart Kymera Therapeutics Stock Chart Fusion Pharmaceuticals Stock Chart Inhibrx Stock Chart Sana Biotechnology Stock Chart Neumora Therapeutics Stock Chart Vir Biotechnology Stock Chart BioCryst Pharmaceuticals Stock Chart Cullinan Therapeutics Stock Chart Receive LXEO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexeo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LXEO) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredNvidia has Apple and Microsoft within striking rangeA small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. W...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexeo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexeo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.